Traditional reactive carbonyl scavengers do not prevent the carbonylation of brain proteins induced by acute glutathione depletion

Free Radical Research

Volumn 44, Issue 3, 2010, Pages 258-266

  Zheng, J ^a   Bizzozero, O A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Carbonyl scavengers; Glutathione depletion; Hydralazine; Oxidative stress; Protein carbonylation; Reactive oxygen species

Indexed keywords

ACROLEIN; AMINOGUANIDINE; BRAIN PROTEIN; CARBONYL DERIVATIVE; CARNOSINE; GLUTATHIONE; HISTIDINE DERIVATIVE; HYDRALAZINE; MALEIC ACID DIETHYL ESTER; MALONALDEHYDE; METHOXYAMINE; PYRIDOXAMINE; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBONYLATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; BLOTTING, WESTERN; BRAIN; FREE RADICAL SCAVENGERS; GLUTATHIONE; MALE; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 77249109368     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715760903456092     Document Type: Article

References (38)

1. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 1997;10: 485-494.
2. Levine RL. Carbonyl modifi ed proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002;32:790-796.
3. Aksenov MY, Aksenova MV, Butterfi eld DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001;103:373-383.
4. Floor E, Wetzel MG. Increased protein oxidation in human sustantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitroph-enylhydrazine assay. J Neurochem 1998;70:268-275.
5. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH, Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997;69: 2064-2074.
6. Bizzozero OA, Dejesus G, Callahan K, Pastuszyn A. Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis. J Neurosci Res 2005;81: 687-695. (Pubitemid 41532164)
7. Adams S, Green P, Claxton R, Simcox S, Williams MV, Walsh K, Leeuwenburgh C. Reactive carbonyl formation by oxidative and non-oxidative pathways. Front Biosci 2001;6:17-24.
8. Bizzozero OA, Ziegler JL, DeJesus G, Bolognani F. Acute depletion of reduced glutathione causes extensive carbonyla-tion of rat brain proteins. J Neurosci Res 2006;83: 656-667.
9. Bizzozero OA, Reyes S, Ziegler JL, Smerjac S. Lipid peroxida-tion scavengers prevent the carbonylation of cytoskeletal brain proteins induced by glutathione depletion. Neurochem Res 2007;32:2114-2122.
10. Zheng J, Reyes S, Bizzozero OA. Effect of hydralazine and other carbonyl scavengers at preventing the carbonylation of brain proteins induced by GSH depletion. J Neurochem 2008;104(Suppl 1):PTW06-PTW15.
11. Nourooz-Zadeh A, Tajaddini-Sarmadi J, Ling KL, Wolff S P. Low-density lipoprotein is the major carrier of lipid hydroper-oxides in plasma. Biochem J 1996;313:781-786.
12. Riddles PW, Blakely RL, Zerner B. Ellman's reagent: 5,5'-dithiobis (2-nitrobenzoic acid)-a reexamination. Anal Biochem 1979;94:75-81.
13. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
14. Semsei I, Nagy K, Zs-Nagy I. In vitro studies on the OH and O2-free radical scavenger properties of idebenone in chemical systems. Arch Gerontol Geriatr 1990;11:187-197.
15. Buchmuller-Rouiller Y, Corrandin SB, Smith J, Schneider P, Ransijn A, Jongeneel CV, Mauel J. Role of glutathione in mac-rophage activation: effect of cellular glutathione depletion on nitrite production and leishmanicidal activity. Cell Immunol 1995;164:73-80.
16. Kaminskas LM, Pyke SM, Burcham PC. Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. J Pharmacol Exp Ther 2004;310:1003-1010.
17. Al-Abed Y, Bucala R. Effi cient scavenging of fatty acid oxidation products by aminoguanidine. Chem Res Toxicol 1997;10: 875-879.
18. Tang SC, Arumugam TV, Cutler RG, Jo DG, Magnus T, Chan SL, Mughal MR, Telljohann, RS, Nassar M, Ouyang X, Calderan A, Ruzza P, Guiotto A, Mattson MP. Neuroprotective actions of a histidine analogue in models of ischemic stroke. J Neurochem 2007;101:729-736.
19. Burcham PC, Fontaine FR, Kaminskas LM, Petersen DR, Pyke SM. Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. Mol Pharmacol 2004;65:655-664.
20. Voziyan PA, Metz TO, Baynes JW, Hudson BG. A post-amadori inhibitor pyridoxamine also inhibits chemical modi-fi cation of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 2002;277: 3397-3403.
21. Hipkiss AR, Brownson C. A possible new role for the anti-aging peptide carnosine. Cell Mol Life Sci 2000;57: 747-753.
22. Devamanoharan PS, Ali AH, Varma SD. Prevention of lens protein glycation by taurine. J Mol and Cell Biochem 1997;177: 245-250.
23. Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end oxidative damage to proteins. Potential diseases and therapeutic prospects inhibitors. Br J Pharmacol 2008;153:6-20.
24. Münzel T, Kurz S, Rajagopalan S, Thoenes M, Berrington WR, Thompson JA, Freeman BA, Harrison DG. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest 1996;98:1465-1470.
25. Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 1996;16:6394-6401.
26. t Hart BA, Simons JM, Knaan-Shanzer S, Bakker NP, Labadie R P, Antiarthritic activity of the newly developed neu-trophil oxidative burst antagonist apocynin. Free Radic Biol Med 1990, 9:127-131.
27. Roh JH, Suzuki H, Azakami H, Yamashita M, Murooka Y, Kumagai H. Purifi cation, characterization, and crystallization of monoamine oxidase from Escherichia coli. Biosci Biotech-nol Biochem 1994;58:1652-1656. (Pubitemid 2159925)
28. Kishi H, Kishi T, Folkers K. Bioenergetics in clinical medicine. III. Inhibition of conezyme Q10-enzymes by clinically used antihypertensive agents. Res Commun Chem Pathol Pharmacol 1975;12:533-540.
29. Daiber A, Oelze M, Coldewey M, Kaiser K, Huth C, Schildknecht S, Bachschmid M, Nazirisadeh Y, Ullrich V, Mülsch A, Münzel T, Tsilimingas N. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its benefi cial effects on prognosis in patients with congestive heart failure. Biochem Biophys Res Commun 2005;338:1865-1874.
30. Refsgaard HF, Tsai L, Stadman ER. Modifi cation of proteins by polyunsaturated fatty acid peroxidation products. Proc Natl Acad Sci USA 2000;97:611-691.
31. Pennathur S, Ido Y, Heller JI, Byun J, Danda R, Pergola P, Williamson JR, Heinecke J W. Reactive carbonyls and polyun-saturated fatty acids produce hydroxyl radical-like species. J Biol Chem 2005;280:22706-22714.
32. Bizzozero OA. Protein carbonylation in neurodegenerative and demyelinating CNS diseases. In: Lajtha, Banik, Ray, editors. Handbook of neurochemistry and molecular neurobiology-Brain and spinal cord trauma. Springer; 2008. Chapter 23. p. 543-562.
33. Smerjac S, Bizzozero OA. Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomy-elitis. J Neurochem 2008;105:763-772.
34. Requena JS, Chao CC, Levine R, Stadtman ER. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 2001;98:69-74.
35. Pamplona R, Dalfo E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, Portero-Otin M. Proteins in human brain cortex are modifi ed by oxidation, glycoxidation, and lipoxidation. J Biol Chem 2005;280:21522-21530.
36. Metha R, Wong L, O'Brien PJ. Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes. Chem-Biol Interact 2009;178:317-323.
37. Leiro JM, Alvarez E, Arranz JA, Cano E, Orallo F. Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in peritoneal mac-rophages. Int Immunopharmacol 2004;4:163-177.
38. Svensson CK, Knowlton PW, Ware JA. Effect of hydralazine on the elimination of antipyrine in the rat. Pharm Res 1987;4:515-518.